Waxman Strategies Examines Publicly Funded Contraceptive Access: Existing Streams, Current Gaps, and Incoming Threats
By: Zara Day, Kate Meyer, Helen Robins, Anna Britt
In partnership with The Commonwealth Fund, Waxman Strategies conducted deep policy research in 2024 and 2025 exploring public funding streams for contraception, focusing on Medicaid, Title X, and Title V. In the wake of major policy shifts at the federal level, Waxman Strategies also explored how changes in public funding could diminish contraceptive access across the country, especially for people with low incomes, people of color, and other marginalized communities.
As the culmination of this work, our team authored an issue brief examining publicly funded access to contraceptives, threats to this access nationwide, as well as opportunities for states to increase access to contraceptive equity, access, and choice. Waxman Strategies also authored two blog posts that provide a deeper dive into how cuts to Medicaid and threats to end the Title X Program would impact contraceptive access.
Read the series at the links below:
Issue Brief — An Overview of Federally Funded Contraceptive Programs: deep dives into publicly funded access points to contraceptives, existing challenges and gaps within these streams, expected impacts of recent federal funding changes to the health care safety net, and opportunities for states to tailor their programs to meet contraceptive needs amidst this changing federal landscape.
Blog — Changes to Medicaid Threaten Contraceptive Accessibility: examines the importance of Medicaid in increasing access to contraceptives in the U.S. and how recent passage of the federal funding bill — H.R. 1 — in combination with the expiration of enhanced premium tax credits will threaten the landscape of contraceptive care across the country.
Blog — Reducing or Eliminating the Title X Family Planning Program Would Restrict Contraceptive Access Nationwide: showcases the value of the Title X program and how proposed funding cuts in the FY2026 healthcare appropriations bill could lead to up to 2.8 million people losing access to essential contraceptive and preventive care.